Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
$25.60
0.0%
$25.60
$24.07
$25.80
$7.68M0.271,842 shs500 shs
DUKX
Ocean Park International ETF
$24.70
+0.3%
$23.97
$20.98
$26.64
$2.72MN/A1,053 shs224 shs
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
$25.22
0.0%
$0.00
$0.00
$0.00
N/AN/AN/A2 shs
MCRO
IQ Hedge Macro Tracker ETF
$25.80
+0.0%
$25.80
$24.39
$27.81
$2.58MN/A515 shs100 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
0.00%0.00%0.00%0.00%0.00%
DUKX
Ocean Park International ETF
0.00%+1.15%+2.71%+6.53%-1.99%
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
0.00%+1.02%+2.43%+6.84%+10.61%
MCRO
IQ Hedge Macro Tracker ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
N/AN/AN/AN/AN/AN/AN/AN/A
DUKX
Ocean Park International ETF
N/AN/AN/AN/AN/AN/AN/AN/A
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
0.00
N/AN/AN/A
DUKX
Ocean Park International ETF
0.00
N/AN/AN/A
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
0.00
N/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
N/AN/AN/AN/AN/AN/A
DUKX
Ocean Park International ETF
N/AN/AN/AN/AN/AN/A
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
N/AN/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
N/AN/A18.48N/AN/AN/AN/AN/A
DUKX
Ocean Park International ETF
N/AN/A14.84N/AN/AN/AN/AN/A
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
N/AN/A0.00N/AN/AN/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
$0.833.24%N/AN/AN/A
DUKX
Ocean Park International ETF
$0.712.87%N/AN/AN/A
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
N/A2.40%N/AN/AN/A
MCRO
IQ Hedge Macro Tracker ETF
$0.622.40%N/AN/AN/A

Latest MAPP, CPI, DUKX, and MCRO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/26/2025
DUKX
Ocean Park International ETF
Quarterly$0.20393.42%6/27/20256/27/20257/2/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
IQ Real Return ETF stock logo
CPI
IQ Real Return ETF
N/A300,000N/ANot Optionable
DUKX
Ocean Park International ETF
N/A110,000N/AN/A
MAP Pharmaceuticals Inc. stock logo
MAPP
MAP Pharmaceuticals
N/AN/AN/ANot Optionable
MCRO
IQ Hedge Macro Tracker ETF
147,000100,000N/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

IQ Real Return ETF stock logo

IQ Real Return ETF NYSEARCA:CPI

$25.60 -0.01 (-0.04%)
As of 12/12/2023

CPI Inflation Hedged ETF seeks investment results, which correspond to the price and yield performance of the IQ CPI Inflation Hedged Index. The Index seeks to provide a hedge against the United States inflation rate by providing a real return or a return above the rate of inflation, as represented by the Consumer Price Index, which is published by the Bureau of Labor Statistics and is a measure of the average change in prices over time of goods and services purchased by households.

Ocean Park International ETF NASDAQ:DUKX

$24.70 +0.08 (+0.32%)
As of 09:36 AM Eastern

The Ocean Park International ETF (DUKX) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds that tactically allocates across international equity ETFs. The fund seeks to provide total return while mitigating downside risk DUKX was launched on Jul 10, 2024 and is issued by Ocean Park.

MAP Pharmaceuticals stock logo

MAP Pharmaceuticals NASDAQ:MAPP

MAP Pharmaceuticals, Inc., incorporated on July 3, 2003, is a development-stage company. As of December 31, 2011, the Company was focusing to advance its product candidate, LEVADEX (MAP0004) orally inhaled migraine therapy, which is an orally inhaled version of dihydroergotamine mesylate (DHE), for the acute treatment of migraine. The Company had completed clinical development for LEVADEX in 2011 and submitted its New Drug Application (NDA) to the United States Food and Drug Administration (FDA). LEVADEX is at-home therapy in development that patients self-administer using its hand-held TEMPO inhaler. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc.

IQ Hedge Macro Tracker ETF NYSEARCA:MCRO

$25.80 +0.01 (+0.04%)
As of 01/31/2023

IQ Hedge Macro Tracker ETF (the Fund) is an exchange-traded fund that seeks to track, before fees and expenses, the performance of the IQ Hedge Macro Index (the Index). The Index seeks to replicate the risk-adjusted return characteristics of hedge funds that employ various hedge fund investment styles, which may include but are not limited to long/short equity, macro, market neutral, event-driven, fixed-income arbitrage, emerging markets and other strategies commonly used by hedge fund managers (the Strategy). The Fund is a fund of funds as each invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its Index, which includes underlying funds. The Fund's investment advisor is IndexIQ Advisors LLC and its sub-advisor is Mellon Capital Management Corporation.